Port, Helena
Holm Nielsen, Signe
Frederiksen, Peder
Madsen, Sofie Falkenløve
Bay-Jensen, Anne-Christine
Sørensen, Inge Juul
Jensen, Bente
Loft, Anne Gitte
Madsen, Ole Rintek
Østergaard, Mikkel
Pedersen, Susanne Juhl
Funding for this research was provided by:
Royal Library, Copenhagen University Library
Article History
Received: 2 May 2023
Accepted: 31 July 2023
First Online: 25 August 2023
Declarations
:
: Both studies were approved by the Regional Committee on Health Research Ethics and the Danish Medicines Agency, Denmark. All patients provided written informed consent before being included in the studies.
: Not applicable.
: Ms. Port has received a Ph.D. grant from Innovation Fund Denmark. Dr. Nielsen, Mr. Frederiksen, Dr. Bay-Jensen are employed at and owns stocks in Nordic Bioscience A/S. Dr. Loft has received research grant from Novartis, and speaking and/or consulting fees from AbbVie, Janssen, Lilly, MSD, Novartis, Pfizer, Roche, and UCB Dr. Østergaard has received research grants from AbbVie, BMS, Merck, Novartis and UCB, and speaker and/or consultancy fees from AbbVie, BMS, Boehringer-Ingelheim, Celgene, Eli-Lilly, Galapagos, Gilead, Hospira, Janssen, MEDAC, Merck, Novartis, Novo Nordisk, Orion, Pfizer, Regeneron, Roche, Sandoz, Sanofi, and UCB.Dr. Pedersen has received grants and contracts from Innovation Fund Denmark and Nordic Bioscience A/S, consulting fees, speaking fees, and/or research support from AbbVie, Novartis, MSD, Pfizer, and UCB.